PHASE4 VENTURES
Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US and Europe. Founded in 1999, the team has made close to 30 investments in Life Science companies alongside other top tier venture capital firms in both Europe and the US. The team is complemented by an extensive group of advisors with operating experience at a senior level in pharmaceutical and biotechnology companies. Phase4 Ventures' investments include many of the compa... nies that have provided successful European and US venture exits including Intercell, Pharmion, Targacept and most recently Proteolix. Phase4 Ventures was spun-out from Nomura in December 2010 following a buy out of the management company by the team and a secondary purchase of a fund by HarbourVest Partners. Phase4 Ventures currently manages funds for both Nomura and HarbourVest. Phase4 Ventures Limited is a member of the British Private Equity and Venture Capital Association (BVCA) and the European Private Equity and Venture Capital Association (EVCA).
PHASE4 VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
1999-01-01
Status:
Closed
Contact:
44 203 036 0050
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2009-08-06 | Zosano Pharma | Phase4 Ventures investment in Series B - Zosano Pharma | 30 M USD |
2008-11-04 | OncoMed Pharmaceuticals | Phase4 Ventures investment in Series B - OncoMed Pharmaceuticals | 154 M USD |
2008-09-08 | Proteolix | Phase4 Ventures investment in Series C - Proteolix | 79 M USD |
2007-11-15 | Zosano Pharma | Phase4 Ventures investment in Series A - Zosano Pharma | 90 M USD |
2007-09-04 | Nabriva Therapeutics | Phase4 Ventures investment in Venture Round - Nabriva Therapeutics | 56 M USD |
2007-03-08 | Phenomix | Phase4 Ventures investment in Series C - Phenomix | 55 M USD |
2006-04-03 | Chroma Therapeutics | Phase4 Ventures investment in Series C - Chroma Therapeutics | 53 M USD |
2006-02-10 | ARYx Therapeutics | Phase4 Ventures investment in Series E - ARYx Therapeutics | 30.4 M USD |
2005-10-26 | Cerimon Pharmaceuticals | Phase4 Ventures investment in Series A - Cerimon Pharmaceuticals | 70 M USD |
2004-06-01 | ARYx Therapeutics | Phase4 Ventures investment in Series D - ARYx Therapeutics | 55 M USD |